The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug

Area of Science:

• Biochemistry
• Cancer Biology
• Pharmacology

Background:

• Metformin is a widely used biguanide drug for diabetes.
• Metformin significantly impacts cellular metabolism and energy balance.
• Epidemiological studies suggest a reduced cancer risk in diabetic patients treated with metformin.

Purpose of the Study:

• To review the current understanding of molecular mechanisms underlying metformin's anticancer effects.
• To focus on cell-autonomous mechanisms influencing cancer cell growth and death.

Main Methods:

• Review of in vivo and in vitro studies on metformin's anticancer properties.
• Discussion of molecular pathways perturbed by metformin treatment relevant to antitumour activity.

Main Results:

• Metformin treatment perturbs cell metabolism and energy balance.
• Evidence suggests metformin possesses antitumour activities through various mechanisms.
• Cell-autonomous effects on cancer cell proliferation and apoptosis are key areas of investigation.

Conclusions:

• Metformin's profound effects on cell metabolism are linked to its potential anticancer properties.
• Further elucidation of molecular mechanisms is crucial for understanding metformin's antitumour role.
• Focusing on cell-autonomous pathways provides insight into how metformin affects cancer cells directly.